Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC): A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process

Neoadjuvant chemotherapy (NC) improves overall survival in patients with resectable muscle-invasive urothelial cancer of the bladder (MIBC). However uptake of NC in Canada is dis-appointingly low. Following a detailed literature review and in consultation with urologic oncology, the Canadian Associa...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Seah, Jo-An, Blais, Normand, North, Scott, Rahim, Yasmin, Ruether, Dean, Black, Peter C., Zlotta, Alexandre R., Wood, Lori, Sridhar, Srikala S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Canadian Medical Association 2013
Onderwerpen:
Consensus Statement
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854467/
https://ncbi.nlm.nih.gov/pubmed/24319508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.1506
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items